BioRestorative Therapies, Inc. (BRTX)
0.2185
-0.05
(-18.47%)
USD |
NASDAQ |
Feb 20, 16:00
0.209
-0.01
(-4.35%)
After-Hours: 20:00
BioRestorative Therapies EPS Diluted (Quarterly) : -0.3333 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Immunic, Inc. | -0.1319 |
| Quince Therapeutics, Inc. | -0.2492 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.038M |
| Revenue (Quarterly) | 0.0118M |
| Total Expenses (Quarterly) | 3.050M |
| Enterprise Value | -2.536M |
| Gross Profit Margin (Quarterly) | -435.6% |
| Profit Margin (Quarterly) | -25.75K% |
| Earnings Yield | -692.3% |
| Normalized Earnings Yield | -753.78 |